e-learning
resources
Stockholm 2007
Monday 17.09.2007
Bronchoscopic staging modalities in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?
K. G. Tournoy, L. Vanwalleghem, F. De Rijck, M. Praet, F. Vermassen, G. Van Maele, J. van Meerbeeck (Ghent, Belgium)
Source:
Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Session:
Bronchoscopic staging modalities in lung cancer
Session type:
Oral Presentation
Number:
2673
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. G. Tournoy, L. Vanwalleghem, F. De Rijck, M. Praet, F. Vermassen, G. Van Maele, J. van Meerbeeck (Ghent, Belgium). Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?. Eur Respir J 2007; 30: Suppl. 51, 2673
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Results of echoendoscopic ultrasound in mediastinal nodal staging of lung cancer
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012
The impact of ultrasonography-guided fine needle aspiration of non-palpable supraclavicular lymph nodes on diagnosis and staging in advanced lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005
Probability model for malignancy in hilar and mediastinal lymph nodes in lung cancer based on PET-CT and EBUS
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019
EUS-FNA and EBUS: the role of ultrasound in endoscopic diagnosis of mediastinal lymph nodes
Source: Annual Congress 2007 - EUS-FNA and EBUS: the role of ultrasound in endoscopic diagnosis of mediastinal lymph nodes
Year: 2007
Role of molecular and cellular techniques applied to EBUS-TBNA of mediastinal lymph nodes for lung cancer staging
Source: Annual Congress 2012 - EBUS-TBNA: a never ending story
Year: 2012
Evaluation of the integrated PET/CT and the EBUS-TBNA of lymph nodes in patients with suspected cancer
Source: Annual Congress 2010 - Are needles enough: the value of different approaches
Year: 2010
Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies
Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging
Year: 2004
Sampling of ipsilateral mediastinal nodes by EBUS-TBNA in lung cancer staging
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007
EBUS-TBNA for mediastinal restaging
Source: Annual Congress 2006 - Lung cancer staging and miscellaneous
Year: 2006
The influence of nodal size on EUS-FNA outcomes for mediastinal staging of NSCLC
Source: Annual Congress 2010 - Are needles enough: the value of different approaches
Year: 2010
EBUS-TBNA
vs
mediastinoscopy for the staging of lung cancer
Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy
Year: 2006
Assessment of the negative predictive value (NPV) of endobronchial ultrasound-guided real-time needle aspiration (EBUS-rtNA) in mediastinal lymph node staging in patients with lung cancer based on surgical results
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=163
Year: 2007
Preoperative endobronchial ultrasound (EBUS) for mediastinal staging in patients with lung carcinoma
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007
Endobronchial ultrasound elastography type classification in the diagnosis of mediastinal and hilar lymph nodes
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept